Generative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led...
Up To Date
Latest News
British and Italian researchers have demostrated promising results in patients with progressive multiple...
French Sanofi SA’s second Phase III trial of duplimab demonstrated a 34% reduction in exacerbations and...
In the race for global market share of its obesity and diabetes blockbuster semaglutide, Novo Nordisk is...
Flagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at ...
Finnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein...